155 related articles for article (PubMed ID: 11712786)
41. The prognostic significance of apoptosis-associated proteins BCL-2, BAX and BCL-X in clinical nephroblastoma.
Ghanem MA; Van der Kwast TH; Den Hollander JC; Sudaryo MK; Van den Heuvel MM; Noordzij MA; Nijman RJ; Soliman EH; van Steenbrugge GJ
Br J Cancer; 2001 Nov; 85(10):1557-63. PubMed ID: 11720445
[TBL] [Abstract][Full Text] [Related]
42. [Immunohistochemical evaluation of the percentage of proliferating neoplastic cells of Wilms' tumor in children by means of the MIB-1 monoclonal antibody].
Juszkiewicz P
Ann Acad Med Stetin; 1997; 43():113-27. PubMed ID: 9471911
[TBL] [Abstract][Full Text] [Related]
43. Changes in WT1 splicing are associated with a specific gene expression profile in Wilms' tumour.
Baudry D; Faussillon M; Cabanis MO; Rigolet M; Zucker JM; Patte C; Sarnacki S; Boccon-Gibod L; Junien C; Jeanpierre C
Oncogene; 2002 Aug; 21(36):5566-73. PubMed ID: 12165855
[TBL] [Abstract][Full Text] [Related]
44. Decreased E-cadherin expression correlates with higher stage of Wilms' tumors.
Safford SD; Freemerman AJ; Langdon S; Bentley R; Goyeau D; Grundy PE; Skinner MA
J Pediatr Surg; 2005 Feb; 40(2):341-8. PubMed ID: 15750927
[TBL] [Abstract][Full Text] [Related]
45. Expression of E-cadherin, cadherin-11, alpha-, beta- and gamma-catenins in nephroblastomas: relationship with clinicopathological parameters, prognostic factors and outcome.
Ramburan A; Hadley GP; Govender D
Pathology; 2006 Feb; 38(1):39-44. PubMed ID: 16484007
[TBL] [Abstract][Full Text] [Related]
46. Effect of duration of treatment on treatment outcome for patients with clear-cell sarcoma of the kidney: a report from the National Wilms' Tumor Study Group.
Seibel NL; Li S; Breslow NE; Beckwith JB; Green DM; Haase GM; Ritchey ML; Thomas PR; Grundy PE; Finklestein JZ; Kim T; Shochat SJ; Kelalis PP; D'Angio GJ
J Clin Oncol; 2004 Feb; 22(3):468-73. PubMed ID: 14752069
[TBL] [Abstract][Full Text] [Related]
47. [Combined preoperative radio- and chemotherapy of nephroblastoma (Wilms' tumor)].
Hünig R; Laug W; Wagner HP; Walther E
Strahlentherapie; 1974 Feb; 147(2):117-28. PubMed ID: 4368087
[No Abstract] [Full Text] [Related]
48. Partial nephrectomy for unilateral Wilms tumor: results of study SIOP 93-01/GPOH.
Haecker FM; von Schweinitz D; Harms D; Buerger D; Graf N
J Urol; 2003 Sep; 170(3):939-42; discussion 943-4. PubMed ID: 12913746
[TBL] [Abstract][Full Text] [Related]
49. [Antitumor antibiotics in the treatment of nephroblastomas in children].
Badalian GKh; Lebedev VI; Gusev LI; Dolgushin BI
Antibiotiki; 1984 Sep; 29(9):676-8. PubMed ID: 6095749
[TBL] [Abstract][Full Text] [Related]
50. The prognostic relevance of preoperative transcatheter arterial chemoembolization (TACE) and PCNA/VEGF expression in patients with Wilms' tumour.
Liu WG; Gu WZ; Zhou YB; Tang HF; Li MJ; Ma WX
Eur J Clin Invest; 2008 Dec; 38(12):931-8. PubMed ID: 19021718
[TBL] [Abstract][Full Text] [Related]
51. Predictors of response to chemo-radiotherapy and radiotherapy for esophageal squamous cell carcinoma.
Miyazaki T; Kato H; Faried A; Sohda M; Nakajima M; Fukai Y; Masuda N; Manda R; Fukuchi M; Ojima H; Tsukada K; Kuwano H
Anticancer Res; 2005; 25(4):2749-55. PubMed ID: 16080521
[TBL] [Abstract][Full Text] [Related]
52. Anaplastic sarcoma of the kidney: a clinicopathologic study of 20 cases of a new entity with polyphenotypic features.
Vujanić GM; Kelsey A; Perlman EJ; Sandstedt B; Beckwith JB
Am J Surg Pathol; 2007 Oct; 31(10):1459-68. PubMed ID: 17895746
[TBL] [Abstract][Full Text] [Related]
53. Microsatellite analysis of the adenomatous polyposis coli (APC) gene and immunoexpression of beta catenin in nephroblastoma: a study including 83 cases treated with preoperative chemotherapy.
Ramburan A; Oladiran F; Smith C; Hadley GP; Govender D
J Clin Pathol; 2005 Jan; 58(1):44-50. PubMed ID: 15623481
[TBL] [Abstract][Full Text] [Related]
54. [Cover image. Bilateral nephroblastomatosis with secondary Wilms tumor manifestations].
Horger MS; Fendel A
Rofo; 2003 Apr; 175(4):453-4. PubMed ID: 12765189
[No Abstract] [Full Text] [Related]
55. Immunohistochemical analysis of gamma catenin in Wilms' tumors.
Basta-Jovanovic G; Gvozdenovic E; Dimitrijevic I; Brasanac D; Jovanovic M; Kalezic N; Baralic I; Radojevic-Skodric S; Arsic D
Fetal Pediatr Pathol; 2008; 27(2):63-70. PubMed ID: 18568994
[TBL] [Abstract][Full Text] [Related]
56. Increased tissue factor expression and poor nephroblastoma prognosis.
Maciel EO; Carvalhal GF; da Silva VD; Batista EL; Garicochea B
J Urol; 2009 Oct; 182(4):1594-9. PubMed ID: 19683742
[TBL] [Abstract][Full Text] [Related]
57. Examination of expression of WT1 gene product and CD44 adhesive molecule in nephroblastoma histologic types.
Taran K; Kobos J; Sporny S
Pol J Pathol; 2008; 59(3):177-82. PubMed ID: 19097357
[TBL] [Abstract][Full Text] [Related]
58. [Preoperative chemotherapy of nephroblastomas in children].
Lebedev VI; Badalian GKh; Gusev LI
Urol Nefrol (Mosk); 1984; (4):25-7. PubMed ID: 6089397
[No Abstract] [Full Text] [Related]
59. Overexpression of survivin mRNA is associated with a favorable prognosis following neoadjuvant radiochemotherapy in esophageal cancer.
Warnecke-Eberz U; Hokita S; Xi H; Higashi H; Baldus SE; Metzger R; Brabender J; Bollschweiler E; Mueller RP; Dienes HP; Hoelscher AH; Schneider PM
Oncol Rep; 2005 Jun; 13(6):1241-6. PubMed ID: 15870949
[TBL] [Abstract][Full Text] [Related]
60. [Expression of Hsp70 and Hdj1 chaperone proteins in human tumor cells].
Novoselov SS; Verbova MV; Vasil'eva EV; Vorob'ëva NK; Margulis BA; Guzhova IV
Vopr Onkol; 2004; 50(2):174-8. PubMed ID: 15176219
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]